These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 17595476

  • 41. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U.
    Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928
    [Abstract] [Full Text] [Related]

  • 42. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [Abstract] [Full Text] [Related]

  • 43. Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.
    Karacorlu M, Karacorlu S, Ozdemir H.
    Jpn J Ophthalmol; 2003 Feb; 47(6):595-8. PubMed ID: 14636851
    [Abstract] [Full Text] [Related]

  • 44. Transpupillary thermotherapy for occult subfoveal choroidal neovascularization: a 1-year, prospective randomized pilot study.
    Gustavsson C, Agardh E.
    Acta Ophthalmol Scand; 2005 Apr; 83(2):148-53. PubMed ID: 15799724
    [Abstract] [Full Text] [Related]

  • 45. One-year results of photodynamic therapy for small predominantly classic choroidal neovascular membranes secondary to age-related macular degeneration.
    Doyle E, Khanwala M, Shah SP, Ong DG, Casswell AG.
    Eur J Ophthalmol; 2007 Apr; 17(5):760-7. PubMed ID: 17932852
    [Abstract] [Full Text] [Related]

  • 46. Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).
    Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU.
    Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1085-95. PubMed ID: 17219106
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation.
    Newsom RS, McAlister JC, Saeed M, McHugh JD.
    Br J Ophthalmol; 2001 Feb; 85(2):173-8. PubMed ID: 11159481
    [Abstract] [Full Text] [Related]

  • 49. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
    Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, Verteporfin in Photodynamic Therapy (VIP) Study Group.
    Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
    [Abstract] [Full Text] [Related]

  • 50. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).
    Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt KU, Gelisken F.
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):745-54. PubMed ID: 19214552
    [Abstract] [Full Text] [Related]

  • 51. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.
    Kaiser PK, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1132-42. PubMed ID: 16538452
    [Abstract] [Full Text] [Related]

  • 52. Efficacy of transpupillary thermotherapy (TTT) in the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration.
    Ahuja RM, Benner JD, Schwartz JC, Butler JW, Steidl SM.
    Semin Ophthalmol; 2001 Jun; 16(2):81-5. PubMed ID: 15491008
    [Abstract] [Full Text] [Related]

  • 53. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
    Tsai TH, Yang CM, Yang CH, Ho TC, Huang JS, Chen MS.
    Eye (Lond); 2007 Jun; 21(6):721-6. PubMed ID: 16543926
    [Abstract] [Full Text] [Related]

  • 54. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU.
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [Abstract] [Full Text] [Related]

  • 55. Indocyanine green dye-enhanced transpupillary thermotherapy of classic subfoveal choroidal neovascularization.
    Sharma T, Shah N, Gopal L, Shanmugam MP, Bhende P, Bhende M, Shetty NS, Sukumar B.
    Ophthalmic Surg Lasers Imaging; 2004 Sep; 35(3):197-206. PubMed ID: 15185787
    [Abstract] [Full Text] [Related]

  • 56. Retinal function following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration: a short-term study by focal electroretinography.
    Pirozzi E, Manganelli C, Piccardi M, Minnella A, Fadda A, Ziccardi L, Coccimiglio F, Falsini B.
    Acta Ophthalmol Scand; 2006 Feb; 84(1):27-35. PubMed ID: 16445436
    [Abstract] [Full Text] [Related]

  • 57. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM, Lai S, Markey CM.
    Clin Exp Ophthalmol; 2007 Feb; 35(1):24-31. PubMed ID: 17300567
    [Abstract] [Full Text] [Related]

  • 58. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
    Keam SJ, Scott LJ, Curran MP.
    Drugs; 2003 Feb; 63(22):2521-54. PubMed ID: 14609361
    [Abstract] [Full Text] [Related]

  • 59. Transpupillary thermotherapy for the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.
    Tranos P, Singh M, Peter NM, Dhir L, Kon C, Rassam S.
    Acta Ophthalmol Scand; 2004 Oct; 82(5):585-90. PubMed ID: 15453858
    [Abstract] [Full Text] [Related]

  • 60. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
    Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group, Verteporfin in Photodynamic Therapy Study Group.
    Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.